• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Apax, Canadian pension funds in $6B deal for Kinetic Concepts

Apax, Canadian pension funds in $6B deal for Kinetic Concepts

July 13, 2011 By MassDevice staff

Kinetic Concepts

Are the barbarians back at the gate?

In a move harkening the heyday of the leveraged buyout, a private equity firm and two Canadian pension funds agreed to pony up about $6 billion, including acquired debt, for Kinetic Concepts Inc. (NYSE:KCI).

The $68.50-per-share price represents a 6 percent premium on KCI’s $64.49 closing price on Wall Street yesterday and a 16 percent premium on the San Antonio, Texas-based wound management company’s closing price July 5, the day before rumors spread on The Street that KCI was in play.

The transaction is valued at approximately $6.3 billion and includes KCI’s outstanding debt, according to a release put out by Apax Partners. The London-based private equity firm, which bills itself as “an independent global partnership focused solely on long-term investment in growth companies,” has raised more than $33 billion in funds to support deals in the financial & business services, healthcare, media, retail & consumer and technology sectors.

Apax teamed up with the Canada Pension Plan Investment Board and the Public Sector Pension Investment Board to get the deal done.

“The consortium plans to work actively in partnership with the management of KCI to further invest in the global medical products sector to expand the company’s core business, develop innovative products and extend into new geographies where significant opportunities exist,” Apax officials said in a prepared release. The deal is expected to close in the second half of 2011.

The Blackstone Group, the PE colossus with a $16 billion buyout fund and a history of big bets on med-tech, was rumored to be the front-runner in the race for KCI as recently as late last week. The deal is one of the largest leveraged buyouts since before the global recession of 2008.

KCI, founded in 1976, makes products for the wound care, bariatric and critical care markets. It pulled in just over $256 million in profit on $2.02 billion in sales in 2010.

The company has had its share of legal battles with Smith & Nephew Group plc (NYSE:SNN) in their long-running war over negative-pressure wound therapy. The grudge match between the companies has played out in courts in Europe and the U.S., with each notching victories and setbacks.

Filed Under: Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Apax Partners, Kinetic Concepts Inc.

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy